Free weekly newsletter
Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Biorelate Appoints Dr. Ben Sidders As Chief Scientific Officer
PRIVATESep 05, 2024•almost 2 years ago
Position
Chief Scientific Officer
Company
Biorelate
ManchesterBiotechnologyArtificial IntelligenceMachine LearningDescription
Biorelate has announced the appointment of Dr Ben Sidders, a leading pharmaceutical industry data science expert, as Chief Scientific Officer. Dr Sidders brings two decades of deep data science experience from Pfizer and AstraZeneca to spearhead a new growth phase for Biorelate, leveraging advanced data science methods to transform the focus and impact of drug discovery and development.
Related People
Suggested for you
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months